Risk of Arterial Thromboembolism in Patients With Cancer

Journal of the American College of Cardiology

Volumn 70, Issue 8, 2017, Pages 926-938

  Navi, Babak B ^a,b   Reiner, Anne S ^b   Kamel, Hooman ^a   Iadecola, Costantino ^a   Okin, Peter M ^c   Elkind, Mitchell S V ^d,e   Panageas, Katherine S ^b   DeAngelis, Lisa M ^a,b  

^a FEIL FAMILY BRAIN AND MIND RESEARCH INSTITUTE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d Columbia University ^*  (United States)

^e Department of Medicine   (United States)

Author keywords

ischemic stroke; myocardial infarction; thrombosis

Indexed keywords

AGED; CANCER REGISTRY; CLINICAL TRIAL; COMPLICATION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MALE; MULTICENTER STUDY; NEOPLASM; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; THROMBOEMBOLISM; TIME FACTOR; UNITED STATES;

AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEER PROGRAM; THROMBOEMBOLISM; TIME FACTORS; UNITED STATES;

EID: 85026799262     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2017.06.047     Document Type: Article

References (46)

1. Howlader, N., Noone, A.M., Krapcho, M., et al. SEER Cancer Statistics Review, 1975–2013. 2016, National Cancer Institute, Bethesda, MD Available at: http://seer.cancer.gov/csr/1975_2013/ Accessed June 23, 2017.
2. Blom, J.W., Doggen, C.J., Osanto, S., Rosendaal, F.R., Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 293 (2005), 715–722.
3. Gomes, M., Khorana, A.A., Risk assessment for thrombosis in cancer. Semin Thromb Hemost 40 (2014), 319–324.
4. Goff, D.C. Jr., Lloyd-Jones, D.M., Bennett, G., et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63 (2014), 2935–2959.
5. Meschia, J.F., Bushnell, C., Boden-Albala, B., et al. American Heart Association Stroke Council Council on Cardiovascular and Stroke Nursing Council on Clinical Cardiology Council on Functional Genomics and Translational Biology, Council on Hypertension. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 45 (2014), 3754–3832.
6. McSweeney, J.C., Rosenfeld, A.G., Abel, W.M., et al. American Heart Association Council on Cardiovascular and Stroke Nursing Council on Clinical Cardiology Council on Epidemiology and Prevention Council on Hypertension Council on Lifestyle and Cardiometabolic Health, Council on Quality of Care and Outcomes Research. Preventing and experiencing ischemic heart disease as a woman: state of the science: a scientific statement from the American Heart Association. Circulation 133 (2016), 1302–1331.
7. Kim, A.S., Johnston, S.C., Global variation in the relative burden of stroke and ischemic heart disease. Circulation 124 (2011), 314–323.
8. Velders, M.A., Boden, H., Hofma, S.H., et al. Outcome after ST elevation myocardial infarction in patients with cancer treated with primary percutaneous coronary intervention. Am J Cardiol 112 (2013), 1867–1872.
9. Navi, B.B., Singer, S., Merkler, A.E., et al. Recurrent thromboembolic events after ischemic stroke in patients with cancer. Neurology 83 (2014), 26–33.
10. Graus, F., Rogers, L.R., Posner, J.B., Cerebrovascular complications in patients with cancer. Medicine (Baltimore) 64 (1985), 16–35.
11. Moore, R.A., Adel, N., Riedel, E., et al. High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis. J Clin Oncol 29 (2011), 3466–3473.
12. Khorana, A.A., Francis, C.W., Culakova, E., Fisher, R.I., Kuderer, N.M., Lyman, G.H., Thromboembolism in hospitalized neutropenic cancer patients. J Clin Oncol 24 (2006), 484–490.
13. McGale, P., Darby, S.C., Hall, P., et al. Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother Oncol 100 (2011), 167–175.
14. Chen, P.C., Muo, C.H., Lee, Y.T., Yu, Y.H., Sung, F.C., Lung cancer and incidence of stroke: a population-based cohort study. Stroke 42 (2011), 3034–3039.
15. Maduro, J.H., den Dekker, H.A., Pras, E., et al. Cardiovascular morbidity after radiotherapy or chemoradiation in patients with cervical cancer. Int J Radiat Oncol Biol Phys 78 (2010), 1337–1344.
16. Chu, C.N., Chen, S.W., Bai, L.Y., Mou, C.H., Hsu, C.Y., Sung, F.C., Increase in stroke risk in patients with head and neck cancer: a retrospective cohort study. Br J Cancer 105 (2011), 1419–1423.
17. Moser, E.C., Noordijk, E.M., van Leeuwen, F.E., et al. Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma. Blood 107 (2006), 2912–2919.
18. Kuan, A.S., Chen, S.C., Yeh, C.M., et al. Risk of ischemic stroke in patients with gastric cancer: a nationwide population-based cohort study. Medicine (Baltimore), 94, 2015, e1336.
19. Kuan, A.S., Teng, C.J., Wu, H.H., et al. Risk of ischemic stroke in patients with ovarian cancer: a nationwide population-based study. BMC Med, 12, 2014, 53.
20. Navi, B.B., Reiner, A.S., Kamel, H., et al. Association between incident cancer and subsequent stroke. Ann Neurol 77 (2015), 291–300.
21. Zöller, B., Ji, J., Sundquist, J., Sundquist, K., Risk of coronary heart disease in patients with cancer: a nationwide follow-up study from Sweden. Eur J Cancer 48 (2012), 121–128.
22. Aleman, B.M., van den Belt-Dusebout, A.W., De Bruin, M.L., et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 109 (2007), 1878–1886.
23. De Bruin, M.L., Dorresteijn, L.D., van't Veer, M.B., et al. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. J Natl Cancer Inst 101 (2009), 928–937.
24. Tsai, S.J., Huang, Y.S., Tung, C.H., et al. Increased risk of ischemic stroke in cervical cancer patients: a nationwide population-based study. Radiat Oncol, 8, 2013, 41.
25. Nilsson, G., Holmberg, L., Garmo, H., Terent, A., Blomqvist, C., Increased incidence of stroke in women with breast cancer. Eur J Cancer 41 (2005), 423–429.
26. Zöller, B., Ji, J., Sundquist, J., Sundquist, K., Risk of haemorrhagic and ischaemic stroke in patients with cancer: a nationwide follow-up study from Sweden. Eur J Cancer 48 (2012), 1875–1883.
27. Howlader N, Noone AM, Krapcho M, et al. SEER-Medicare Linked Database. Bethesda, MD: National Cancer Institute. Available at: http://healthcaredelivery.cancer.gov/seermedicare/. Accessed June 23, 2017.
28. Khorana, A.A., Kuderer, N.M., Culakova, E., Lyman, G.H., Francis, C.W., Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111 (2008), 4902–4907.
29. Charlson, M.E., Pompei, P., Ales, K.L., MacKenzie, C.R., A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987), 373–383.
30. Kiyota, Y., Schneeweiss, S., Glynn, R.J., Cannuscio, C.C., Avorn, J., Solomon, D.H., Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J 148 (2004), 99–104.
31. Tirschwell, D.L., Longstreth, W.T. Jr., Validating administrative data in stroke research. Stroke 33 (2002), 2465–2470.
32. Parpia, S., Julian, J.A., Thabane, L., Lee, A.Y., Rickles, F.R., Levine, M.N., Competing events in patients with malignant disease who are at risk for recurrent venous thromboembolism. Contemp Clin Trials 32 (2011), 829–833.
33. Gray, R.J., A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16 (1988), 1141–1154.
34. Edge, S.B., Compton, C.C., The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17 (2010), 1471–1474.
35. Carbone, P.P., Kaplan, H.S., Musshoff, K., Smithers, D.W., Tubiana, M., Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31 (1971), 1860–1861.
36. Chamie, K., Williams, S.B., Hershman, D.L., Wright, J.D., Nguyen, P.L., Hu, J.C., Population-based assessment of determining predictors for quality of prostate cancer surveillance. Cancer 121 (2015), 4150–4157.
37. Lee, A.Y., Levine, M.N., Baker, R.I., et al., Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT) Investigators. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 349 (2003), 146–153.
38. Mantia, C., Uhlmann, E.J., Puligandla, M., Weber, G.M., Neuberg, D., Zwicker, J.I., Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin. Blood 129 (2017), 3379–3385.
39. Lyman, G.H., Bohlke, K., Khorana, A.A., et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update 2014. J Clin Oncol 33 (2015), 654–656.
40. Bick, R.L., Cancer-associated thrombosis. N Engl J Med 349 (2003), 109–111.
41. Taccone, F.S., Jeangette, S.M., Blecic, S.A., First-ever stroke as initial presentation of systemic cancer. J Stroke Cerebrovasc Dis 17 (2008), 169–174.
42. Navi, B.B., DeAngelis, L.M., Segal, A.Z., Multifocal strokes as the presentation of occult lung cancer. J Neurooncol 85 (2007), 307–309.
43. Gupta, A., Long, J.B., Chen, J., Gross, C.P., Feldman, D.R., Steingart, R.M., Risk of vascular toxicity with platinum based chemotherapy in elderly patients with bladder cancer. J Urol 195 (2016), 33–40.
44. Li, S.H., Chen, W.H., Tang, Y., et al. Incidence of ischemic stroke post-chemotherapy: a retrospective review of 10,963 patients. Clin Neurol Neurosurg 108 (2006), 150–156.
45. Yu, J.B., Gross, C.P., Wilson, L.D., Smith, B.D., NCI SEER public-use data: applications and limitations in oncology research. Oncology 23 (2009), 288–295.
46. Burke, J.F., Skolarus, L.E., Are more young people having strokes?-A simple question with an uncertain answer. JAMA Neurol 74 (2017), 639–641.